Soul Biotechnology Corporation filed its 10-K on Mar 13, 2023 for the period ending Dec 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+31.49% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.49% | 240B | |
+9.46% | 210B | |
-5.28% | 206B | |
+6.17% | 164B |